Stay updated on HER2 Therapy+Fulvestrant/Capecitabine in HR+/HER2+ MBC Clinical Trial

Sign up to get notified when there's something new on the HER2 Therapy+Fulvestrant/Capecitabine in HR+/HER2+ MBC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the HER2 Therapy+Fulvestrant/Capecitabine in HR+/HER2+ MBC Clinical Trial page

  1. Check
    2 days ago
    No Change Detected
  2. Check
    9 days ago
    No Change Detected
  3. Check
    17 days ago
    Change Detected
    Summary
    The sponsor institution name is updated to Second Affiliated Hospital, Zhejiang University, School of Medicine to reflect the proper organizational naming. The page revision tag is updated to v3.6.5, changing the documented version of the study record.
    Difference
    0.3%
    Check dated 2026-08-08T23:14:00.000Z thumbnail image
  4. Check
    24 days ago
    No Change Detected
  5. Check
    31 days ago
    Change Detected
    Summary
    The page's revision label was updated to v3.6.4, indicating a minor metadata update to the page.
    Difference
    0.0%
    Check dated 2026-07-25T12:56:28.000Z thumbnail image
  6. Check
    53 days ago
    Change Detected
    Summary
    Revision tag on the study page was updated from v3.6.2 to v3.6.3. This indicates a small version update to the page metadata rather than a content change.
    Difference
    0.0%
    Check dated 2026-07-03T23:44:22.000Z thumbnail image
  7. Check
    60 days ago
    Change Detected
    Summary
    The page revision label was updated from v3.6.0 to v3.6.2, indicating a small update to the page rendering.
    Difference
    0.0%
    Check dated 2026-06-27T00:12:49.000Z thumbnail image
  8. Check
    74 days ago
    Change Detected
    Summary
    The study record was updated to standardize the Intervention/Treatment heading, add the investigator name Xuexin He and last-verified status, and include new help sections (How to Read a Study Record, Common Questions, How to Join a Study) with a revision tag Revision: v3.6.0. Removed the older items 'Intervention / Treatment', the full investigator attribution ('xuexin he, Second Affiliated Hospital, School of Medicine, Zhejiang University'), and the previous revision tag (Revision: v3.5.5).
    Difference
    1%
    Check dated 2026-06-12T23:32:44.000Z thumbnail image
  9. Check
    81 days ago
    Change Detected
    Summary
    The page now displays Revision: v3.5.5, replacing the previous v3.5.4. This indicates a minor backend or UI update rather than a change to study details.
    Difference
    0.0%
    Check dated 2026-06-05T18:20:19.000Z thumbnail image

Stay in the know with updates to HER2 Therapy+Fulvestrant/Capecitabine in HR+/HER2+ MBC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the HER2 Therapy+Fulvestrant/Capecitabine in HR+/HER2+ MBC Clinical Trial page.